Crispr stock forecast 2025.

The 68 analysts offering price forecasts for CRISPR Therapeutics have a median target of 81.82, with a high estimate of 168.00 and a low estimate of 37.00. The median estimate represents a 83.90 ...

Crispr stock forecast 2025. Things To Know About Crispr stock forecast 2025.

Editas Medicine Stock Forecast, EDIT stock price prediction. Price target in 14 days: 13.127 USD. The best long-term & short-term Editas Medicine share price prognosis for 2023, 2024, ... Editas Medicine Inc Stock Price Forecast for 2025: February 2025: Open: 0.00171: Close: 0.00000724: Min: 0.00000724: Max: 0.00171: Change: -23550.26 %Get the latest Crispr Therapeutics AG (CRSP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Nov 19, 2023 · CRISPR Therapeutics has a 52 week low of $37.55 and a 52 week high of $72.00. The stock has a market cap of $5.39 billion, a price-to-earnings ratio of -15.19 and a beta of 1.57. CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) last posted its quarterly earnings results on Monday, November 6th. The company reported ($1.41) EPS for the ... Forecast for March 2025. It is predicted that the price of one CRISPR Therapeutics share in will be in the range of $35.26 to $41.70. The width of this range …Web

Detailed Monthly CRISPR Therapeutics (CRSP) Stock Forecast and Prediction for 2025. In the fast-paced biotech industry, forecasting stock performance is a mix of art and science. As we enter 2025, the journey of CRISPR Therapeutics’ stock stands at an intriguing crossroads.If the consensus price target set by Wall Street analysts is to be believed, CRISPR Therapeutics (CRSP-3.43%) stock is going to rise by 49% within the next 12 months.

Despite the pain today, there are a handful of Cathie Wood stocks that could double by 2025. Here are three of them. Despite the pain today, there are a handful of intriguing Cathie Wood stocks Source: rhendrikdwenz via Shutterstock It’s be...

Crispr Therapeutics expects to make history in 2023 with the first-ever request for approval of a gene-editing drug.The bid could stoke long beleaguered CRSP stock. X. The company shares a name ...The current CRISPR Therapeutics AG [ CRSP] share price is $66.73. The Score for CRSP is 52, which is 4% above its historic median score of 50, and infers lower risk than …WebNokia will start 2030 at $6.41, then soar to $6.54 within the first half of the year, and finish 2030 at $6.68. It is about +88% from today. Nokia Stock Price Forecast 2023-2024. Nokia price started in 2023 at $4.64. Today, Nokia traded at $3.49, so the price decreased by -25% from the beginning of the year.NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25.

That's an eye catching number but take a step back and think about it. We hit $5.00 last week. If it doubles in 2021 that's $10.00 and if it doubles again in 2 years by 2023 that's $20.00 leaving 2024 for 30% growth to 26.00. In a growing EV market, with a fully differentiated product.

Join Over Half a Million Premium Members And Get More In-Depth Stock Guidance and Research 2 Stocks That Could Turn $10,000 Into $50,000 by 2025 By Rich Duprey – Jan 7, 2022 at 7:44AM

According to a new report by Citi GPS, the market for CRISPR will go to $10 billion by 2025. It's a big leap considering that the technology hasn't been tested in human trials yet in the US and ...Nokia will start 2030 at $6.41, then soar to $6.54 within the first half of the year, and finish 2030 at $6.68. It is about +88% from today. Nokia Stock Price Forecast 2023-2024. Nokia price started in 2023 at $4.64. Today, Nokia traded at $3.49, so the price decreased by -25% from the beginning of the year.The current CRISPR Therapeutics AG [ CRSP] share price is $66.73. The Score for CRSP is 52, which is 4% above its historic median score of 50, and infers lower risk than normal. CRSP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.Find real-time DNA - Ginkgo Bioworks Holdings Inc stock quotes, company profile, ... EPS forecast (this quarter)-$0.07: Annual revenue (last year) $477.7M: Annual profit (last year)Did I mention that clinical-stage biotech stocks are a great source of jaw-dropping growth over the next decade? CRISPR Therapeutics (CRSP-6.39%), a company leaning on gene-editing technology to precisely alter genomic DNA and tackle hard-to-treat diseases, is expected to see sales climb from $719,000 … See moreInvitae Stock Forecast 11-29-2023. Forecast target price for 11-29-2023: $ 0.55. Positive dynamics for Invitae shares will prevail with possible volatility of 1.756%. Pessimistic target level: 0.54. Optimistic target level: 0.55.

CRISPR Therapeutics. Market Cap. $5B. Today's Change. (-2.22%) -$1.57. Current Price. $69.09. Price as of November 29, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may ...CRISPR Therapeutics (CRSP-0.74%) has been a volatile stock over the past couple of years. Lately, the gene-editing company's shares have been trading for under $51 a share, but I believe they ...Find out the current price target and stock forecast for CRISPR Therapeutics (CRSP)Jan 8, 2022 · Shares of CRISPR Therapeutics ( CRSP -7.40%) sank 50.5% in 2021, according to data from S&P Global Market Intelligence. After surging roughly 151% across 2020's trading, investors reassessed the ... CRISPR Therapeutics will start 2025 at $49.04, then soar to $49.76 within the first six months of the year and finish 2025 at $57.16. That means +48% from today. CRISPR Therapeutics Stock Forecast 2030-2034. In this period, the CRISPR Therapeutics price would rise from $82.55 to $103.44, which is +25%.

Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Ginkgo Bioworks Holdings Inc have a median target of 3.00, with a high estimate of 7.00 and a low estimate of 1.25. The ...

CRISPR Therapeutics will start 2025 at $49.04, then soar to $49.76 within the first six months of the year and finish 2025 at $57.16. That means +48% from today. CRISPR Therapeutics Stock Forecast 2030-2034. In this period, the CRISPR Therapeutics price would rise from $82.55 to $103.44, which is +25%.Find real-time NOK - Nokia Oyj stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter) $0.17: Annual revenue (last year) $26.2B: Annual profit (last year)That's an eye catching number but take a step back and think about it. We hit $5.00 last week. If it doubles in 2021 that's $10.00 and if it doubles again in 2 years by 2023 that's $20.00 leaving 2024 for 30% growth to 26.00. In a growing EV market, with a fully differentiated product.Several genome technologies are under trial for treatment of chronic diseases, and are expected to receive approvals over the forecast period. Global genome engineering market is estimated to be valued at US$ 5.21 billion in 2022 and is expected to exhibit a CAGR of 14.3% during the forecast period (2022-2030). Figure 1.7 years of reliable CRISPR Therapeutics stock forecast. The Wall Street analysts predict Outperform for CRSP. See at a glance whether NasdaqGM:CRSP will …WebThe CRISPR Therapeutics stock prediction results are shown below and presented as a graph, table and text information. CRISPR Therapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for CRISPR Therapeutics analysts is $ 87.78. Today 200 Day Moving Average is the ...Asking AI for help finding triple-digit return biotech stocks reminds investors not to avoid the big names. CRISPR Therapeutics (): The one name that AI produced that isn’t a large-cap stock may ...In 2025, WFC is forecast to generate $303,864,847,647,503 in revenue, ... with the highest WFC stock price forecast at $54.00 and the lowest WFC stock price forecast at $42.00.On average, Wall Street analysts predict. that Wells Fargo & Company's share price could reach $47.64 by Dec 1, 2024.

Dec 10, 2021 · The stock price of CRISPR Therapeutics, a biotechnology gene editing company focused on developing gene-based medicines for human diseases, reached an all-time high of $210 in January of this year ...

Get a real-time CRISPR Therapeutics AG (CRSP) stock price quote with breaking news, financials, statistics, charts and more. Get a real-time ... the average rating for CRSP stock is "Buy." The 12-month stock price forecast is $69.88, which is an increase of 1.79% from the latest price. Price Target. $69.88 (1.79% upside) Analyst ...

METHODOLOGY. DOWNLOAD PDF Brochure. The global gene editing market in terms of revenue was estimated to be worth $5.3 billion in 2023 and is poised to reach $10.6 billion by 2028, growing at a CAGR of …Yahoo Finance. The above is based on 19 Wall Street analysts offering 12-month price targets for CRISPR Therapeutics in the last 3 months. The average price target is $149.11 with a high forecast ...WebCRISPR Therapeutics has a 52 week low of $37.55 and a 52 week high of $72.00. The stock has a market cap of $5.39 billion, a price-to-earnings ratio of -15.19 and a beta of 1.57. CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) last posted its quarterly earnings results on Monday, November 6th. The company reported ($1.41) EPS for the ...2025 CRISPR Therapeutics (CRSP) stock forecast for 2025 Last update: November 28, 2023 (07:48) Sector: Healthcare The share price of CRISPR Therapeutics …WebNext reporting date. February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.The CRISPR Therapeutics stock prediction results are shown below and presented as a graph, table and text information. CRISPR Therapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for CRISPR Therapeutics analysts is $ 87.78. Today 200 Day Moving Average is the ...Asking AI for help finding triple-digit return biotech stocks reminds investors not to avoid the big names. CRISPR Therapeutics (): The one name that AI produced that isn’t a large-cap stock may ...In 2025, AXSM is forecast to generate $29,733,615,914 in revenue, ... with the highest AXSM stock price forecast at $180.00 and the lowest AXSM stock price forecast at $81.00.On average, Wall Street analysts predict. that Axsome Therapeutics's share price could reach $108.43 by Nov 7, 2024.The stock closed last Friday at $13.66 but fell to $9.71 by Thursday, its 52-week low. ... Intellia Therapeutics is down more than 63% so far this year while CRISPR Therapeutics has seen its ...A new market forecast predicts app spending will reach $270 billion by the year 2025, including paid downloads, in-app purchases and subscriptions. According to data from Sensor Tower, in-app spending will return to pre-pandemic levels of s...

Gene Editing Market Size. Gene Editing Market size surpassed USD 5.4 Bn in 2021 and is expected to witness a 15.5% CAGR from 2022 to 2030 owing to an increasing technological advancement driven by the rapidly evolving CRISPR technology with its wide range of applications for gene editing.. To understand key trends Download Free Sample …Week of November 27, 2023 ... NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends ...The share price of CRISPR Therapeutics AG (CRSP) now. What analysts predict: $88.13. 52-week High/Low: $72 / $37.55. 50/200 Day Moving Average: $45.85 / $51.4. This figure corresponds to the Average Price over the previous 50/200 days. For CRISPR Therapeutics stocks, the 50-day moving average is the support level today.Instagram:https://instagram. iep nasdaqportfolio management course onlineyyy.futbolmexicano Dec 10, 2021 · The stock price of CRISPR Therapeutics, a biotechnology gene editing company focused on developing gene-based medicines for human diseases, reached an all-time high of $210 in January of this year ... CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. CRSP updated stock price target summary. buy rating stocksdoes beagle work The stock closed last Friday at $13.66 but fell to $9.71 by Thursday, its 52-week low. ... Intellia Therapeutics is down more than 63% so far this year while CRISPR Therapeutics has seen its ...NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25. collector's insurance Teladoc Health Stock Forecast, TDOC stock price prediction. Price target in 14 days: 19.731 USD. The best long-term & short-term Teladoc Health share price prognosis for ... Teladoc Health Inc Stock Price Forecast for 2025: February 2025: Open: 6.907: Close: 0.125: Min: 0.125: Max: 8.953: Change: -5415.16 % Teladoc Health Inc Stock Price ...Nov 21, 2023 · The CRISPR Therapeutics stock prediction results are shown below and presented as a graph, table and text information. CRISPR Therapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for CRISPR Therapeutics analysts is $ 87.78. Today 200 Day Moving Average is the ... Tattooed Chef Stock Forecast, TTCF stock price prediction. Price target in 14 days: 0.0497 USD. ... Tattooed Chef Inc Stock Price Forecast for 2025: January 2025 ...